CLPT
Income statement / Annual
Last year (2024), ClearPoint Neuro, Inc.'s total revenue was $31.39 M,
an increase of 31.04% from the previous year.
In 2024, ClearPoint Neuro, Inc.'s net income was -$18.91 M.
See ClearPoint Neuro, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$31.39 M |
$23.96 M |
$20.55 M |
$16.30 M |
$12.83 M |
$11.22 M |
$7.35 M |
$7.38 M |
$5.75 M |
$4.59 M |
| Cost of Revenue |
$12.27 M
|
$10.34 M
|
$7.02 M
|
$5.01 M
|
$3.71 M
|
$3.83 M
|
$2.43 M
|
$2.90 M
|
$2.64 M
|
$1.99 M
|
| Gross Profit |
$19.12 M
|
$13.61 M
|
$13.53 M
|
$11.29 M
|
$9.12 M
|
$7.38 M
|
$4.92 M
|
$4.48 M
|
$3.11 M
|
$2.61 M
|
| Gross Profit Ratio |
0.61
|
0.57
|
0.66
|
0.69
|
0.71
|
0.66
|
0.67
|
0.61
|
0.54
|
0.57
|
| Research and Development Expenses |
$12.39 M
|
$11.71 M
|
$10.89 M
|
$8.99 M
|
$4.69 M
|
$2.92 M
|
$2.31 M
|
$2.81 M
|
$2.63 M
|
$1.96 M
|
| General & Administrative Expenses |
$12.00 M
|
$11.76 M
|
$9.61 M
|
$8.76 M
|
$5.27 M
|
$4.30 M
|
$4.33 M
|
$4.05 M
|
$4.19 M
|
$0.00
|
| Selling & Marketing Expenses |
$14.48 M
|
$12.60 M
|
$9.36 M
|
$6.92 M
|
$5.38 M
|
$4.76 M
|
$3.53 M
|
$3.96 M
|
$3.78 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$26.48 M
|
$24.35 M
|
$18.97 M
|
$15.68 M
|
$10.65 M
|
$9.06 M
|
$7.86 M
|
$8.00 M
|
$7.97 M
|
$8.37 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$22,000.00
|
-$63,000.00
|
$882,000.00
|
$9,054.00
|
$364.00
|
$16,682.00
|
$216,075.00
|
$230,875.00
|
| Operating Expenses |
$38.87 M
|
$36.06 M
|
$29.86 M
|
$24.67 M
|
$15.34 M
|
$11.98 M
|
$10.17 M
|
$10.82 M
|
$10.60 M
|
$10.33 M
|
| Cost And Expenses |
$51.14 M
|
$46.40 M
|
$36.88 M
|
$29.67 M
|
$19.05 M
|
$15.81 M
|
$12.60 M
|
$13.72 M
|
$13.24 M
|
$12.32 M
|
| Interest Income |
$872,000.00
|
$386,000.00
|
$81,000.00
|
$973,000.00
|
$1.44 M
|
$955,000.00
|
$0.00
|
$0.00
|
$8,807.00
|
$16,455.00
|
| Interest Expense |
$0.00
|
$0.00
|
$81,000.00
|
$973,000.00
|
$1.44 M
|
$955,166.00
|
$980,383.00
|
$872,926.00
|
$1.06 M
|
$1.26 M
|
| Depreciation & Amortization |
$0.00
|
$1.46 M
|
$777,000.00
|
$692,000.00
|
$550,000.00
|
$250,560.00
|
$109,439.00
|
$116,454.00
|
$155,707.00
|
$211,946.00
|
| EBITDA |
-$19.75 M |
-$20.99 M |
-$15.58 M |
-$12.75 M |
-$4.79 M |
-$4.33 M |
-$5.07 M |
-$6.18 M |
-$6.85 M |
-$6.97 M |
| EBITDA Ratio |
-0.63
|
-0.88
|
-0.76
|
-0.78
|
-0.37
|
-0.39
|
-0.7
|
-0.84
|
-1.24
|
-1.58
|
| Operating Income Ratio |
-0.63
|
-0.94
|
-0.79
|
-0.82
|
-0.48
|
-0.41
|
-0.71
|
-0.86
|
-1.3
|
-1.95
|
| Total Other Income/Expenses Net |
$832,000.00
|
$357,000.00
|
-$103,000.00
|
-$1.04 M
|
-$562,000.00
|
-$945,790.00
|
-$915,701.00
|
-$831,516.00
|
-$581,157.00
|
$524,863.00
|
| Income Before Tax |
-$18.91 M
|
-$22.09 M
|
-$16.44 M
|
-$14.41 M
|
-$6.78 M
|
-$5.54 M
|
-$6.16 M
|
-$7.17 M
|
-$8.07 M
|
-$8.45 M
|
| Income Before Tax Ratio |
-0.6
|
-0.92
|
-0.8
|
-0.88
|
-0.53
|
-0.49
|
-0.84
|
-0.97
|
-1.4
|
-1.84
|
| Income Tax Expense |
$0.00
|
$0.00
|
$103,000.00
|
$910,000.00
|
$2.33 M
|
$964,220.00
|
$64,682.00
|
$889,608.00
|
$1.28 M
|
$1.49 M
|
| Net Income |
-$18.91 M
|
-$22.09 M
|
-$16.54 M
|
-$15.32 M
|
-$9.11 M
|
-$6.50 M
|
-$6.16 M
|
-$7.17 M
|
-$8.07 M
|
-$8.45 M
|
| Net Income Ratio |
-0.6
|
-0.92
|
-0.8
|
-0.94
|
-0.71
|
-0.58
|
-0.84
|
-0.97
|
-1.4
|
-1.84
|
| EPS |
-0.7 |
-0.9 |
-0.68 |
-0.74 |
-0.57 |
-0.49 |
-0.56 |
-0.93 |
-2.93 |
-4.48 |
| EPS Diluted |
-0.7 |
-0.9 |
-0.68 |
-0.74 |
-0.57 |
-0.49 |
-0.56 |
-0.93 |
-2.93 |
-4.48 |
| Weighted Average Shares Out |
$27.03 M
|
$24.61 M
|
$24.18 M
|
$20.73 M
|
$15.85 M
|
$13.16 M
|
$10.93 M
|
$7.74 M
|
$2.75 M
|
$1.88 M
|
| Weighted Average Shares Out Diluted |
$27.03 M
|
$24.61 M
|
$24.18 M
|
$20.73 M
|
$15.85 M
|
$13.16 M
|
$10.93 M
|
$7.74 M
|
$2.75 M
|
$1.88 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
